PIKE Pointsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-04-20
Registered address
ul. Świeradowska 47, 02-662 Warszawa, Poland
Electronic delivery address
AE:PL-84962-45957-TASRJ-13
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 80.47kMedianUSD 129.39kAverageUSD 4.66m
Net profit
This companyUSD 9.29kMedianUSD -37.21AverageUSD 359.84k
Operating costs
This companyUSD 69.82kMedianUSD 167.57kAverageUSD 4.02m
Assets
This companyUSD 78.40kMedianUSD 252.92kAverageUSD 7.45m
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-05-01. Active
44 1050 1025 1000 0090 8162 3036
66 1050 1025 1000 0090 8162 3028
67 1050 1025 1000 0090 8162 3010
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Jędrzej Jan Niewodzki — President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 900 | $12,155.59 | 90% | |
Jędrzej Jan Niewodzki (26) | 100 | $1,350.62 | 10% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Michał Gaweł Niewodzki (34) | Posiada 99% udziałów w spółce goldherd investmets sp. z o. o., która posiada 90% udziałów w spółce pike point sp. z o. o.. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-08-22 | PKD change (Removed: 45.11.Z, 45.20.Z, 45.32.Z; Added: 11.02.Z, 46.71.Z, 47.81.Z, 47.82.Z, 47.92.Z, 72.10.Z, 95.31.A) | |
| 2022-04-20 | Entered in the register |
FAQ
The main business activity of Pike Point focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on April 20, 2022.
The headquarters is located at: ul. Świeradowska 47, 02-662 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $80,467, representing a decrease of 31.3% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $9,291, meaning the company decreased its profit by 27.6%.
The largest operating cost category falls under other operating costs. This category amounted to $44,341 in 2025, representing 64% of all operating expenses.
Last updated: 2026-03-27